POLR3G is selectively upregulated in prostate cancer, for example, in contrast to POLR3GL and the large Pol III subunit POLR3A, which remain unchanged compared to matched normal cells (Petrie et al., 2019). This evidence concerns the gene POLR3G and prostate carcinoma.